Meeder Asset Management Inc Organogenesis Holdings Inc. Transaction History

Meeder Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $2,725 - $5,581	-868 Reduced 90.04%	96 $0
Q2 2022 Aug 08, 2022	BUY	$4.74 - $8.15 $3,749 - $6,446	791 Added 457.23%	964 $5,000
Q1 2022 May 10, 2022	SELL	$6.47 - $9.57 $1,294 - $1,914	-200 Reduced 53.62%	173 $1,000
Q4 2021 Feb 11, 2022	BUY	$9.02 - $13.5 $333 - $499	37 Added 11.01%	373 $4,000
Q3 2021 Nov 08, 2021	BUY	$13.71 - $17.18 $4,346 - $5,446	317 Added 1668.42%	336 $5,000
Q2 2021 Aug 09, 2021	SELL	$14.92 - $23.23 $15,486 - $24,112	-1,038 Reduced 98.2%	19 $0
Q1 2021 Apr 28, 2021	BUY	$7.33 - $21.06 $7,747 - $22,260	1,057 New	1,057 $21,000
Q4 2020 Feb 09, 2021	SELL	$3.63 - $7.53 $9,902 - $20,541	-2,728 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.92 - $5.31 $849 - $1,545	-291 Reduced 9.64%	2,728 $8,000
Q4 2019 Feb 13, 2020	BUY	$4.7 - $8.11 $14,189 - $24,484	3,019 New	3,019 $15,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.